Latest stories

  • in

    Zydus Lifesciences bags USFDA okay for Isoproterenol Hydrochloride Injection

    Zydus Lifesciences bags USFDA okay for Isoproterenol Hydrochloride Injection

    Ahmedabad: Drugmaker, Zydus Lifesciences Limited, has received final approval from the United States Food and Drug Administration (USFDA) to manufacture and market Isoproterenol Hydrochloride Injection USP, 0.2 mg/mL and 1 mg/5 mL (0.2 mg/mL) single-dose vials (USRLD: Isuprel Injection). Isoproterenol hydrochloride injection is indicated to improve hemodynamic status in patients in distributive shock and shock […] More

  • in

    Zydus Lifesciences Depression drug Doxepin Hydrochloride bags USFDA okay

    Ahmedabad: Pharma major, Zydus Lifesciences Limited, has announced that the company has received final approval for Doxepin Hydrochloride Capsules USP, 150 mg (USRLD: Sinequan Capsules) from the United States Food and Drug Administration (USFDA). Doxepin Hydrochloride capsule is indicated to treat mental/mood problems such as depression and anxiety. It helps improve moods and feelings of […] More